Described herein are pharmaceutical packaging units which avert oxidative degradation of morphine, hydromorphone, promethazine and various oxygen-sensitive medications, these types of methods like a syringe with an oxygen permeable idea cap, a hermetically sealed oxygen barrier blister packaging with very very low permeability to oxygen and compris